A program was developed at a 294bed community hospital in Western Massachusetts to educate employees to Hepatitis B Virus Infection (HBVI), determine risk levels, and provide potential protection via immunization. Employee responses to education, baseline and post-vaccination serology (Anti-HBs), and immunization were evaluated . Personnel at HBVI risk were identified. Employees with responsibilities associated with blood, blood products and body fluids exposures were assigned to the Priority 1 Group (P1G)' Employees received information on the education program, HBVI and vaccine. Fifty-three percent attended the education component. Serology screened susceptible employees. Seventeen employees (10%) were Anti-HBs positive. Post vaccination serology documented immunity. A total of 73 people completed the vaccination series with 53 (73%) becoming immune.
INTRODualON
In 1948 Hepatitis B was first recognized as an occupational d isease by physicians of the New York State Workmen's Compensation Board. Novv, various professional organizations have listed groups of health care workers who have an increased risk of acqu iring Hepatitis B Virus (HBV) infection (U.S. Department of Labor, 1983) . Because certain patient populations have a greater incidence of HBV, the risk of infection may be greater for employees serving a high risk area or population (Centers for Disease Control, 1982) .
Much of the available data on personnel suscept ibility to HBV have been derived from larger urban hospitals (Jau-Because certain patient populations have a greater incidence of HB~the risk of infection may be greater for employees serving a high risk population. anovich, 1983) . Smaller hospitals may extrapolate informat ion to determine who is at risk. However, in reality, a smaller hospital may not realize the greater or lesser susceptibility of its employees to HBV infection (Pantelick, 1981) .
For the employee population at Holyoke Hospital Inc., a small urban Western Massachusetts hospital, a signif icant occurrence was an outbreak of HBV MOHN JOURNAL, JANUARY 1987, VOL. 35, NO. 1 
PROGRAM DESIGN AND PURPOSE OF THE STUDY
The Holyoke Hospital committed itself to the protection of its employees against Hepatitis B Virus infection. Individuals at increased risk from occupational infection were identified. A voluntary education program was created to inform personnel of the potential health risks of HBV Serologic testing No. screened the susceptible from immune employees. Each susceptible employee was to sign a consent form indicating an informed decision to receive or decline immunization. Post-immunization serology documented the individual's immunity or lack of it, in which case booster doses of the vaccine were administered. Follow-up testing was scheduled at six and 12 months postvaccination to determine sustained immunity.
The design of the program for HBV and vaccine must consider many ethical, legal, monetary, and employer-employee relationship issues (Baker & Brennan, 1984) . A practical approach to education and vaccine acceptance was published by Anderson and Hodges (1983) . This and other studies state that an education program is an essential component for informing employees about the virus and vaccine.
Our study examines the risk of HBV infection for health care workers in a 294-bed, private, non-profit acute care hospital, the optimal method to reach the target population to educate them to the hazards of HBV infection, the levels of risk, and potential protection by immunization. Of particular importance was the personnel response to the program of education, serologic testing, and immunization.
METHODOLOGY
The targeted risk groups of employees were researched from the literature and finalized after an interview with department managers (U.s. Department of Labor, 1983) . Employees documented at high risk of HBV infection have frequent contact with blood or blood products and body fluids. Employees who had such exposure during direct patient contact or routine employment responsibilities as cited during the department manager interview were assigned to the Hospital's Priority 1 Group (P1G) (Immunization Practices Advisory Committee, 1982). Nursing (N = 213) and Laboratory (N = 54) comprised the majority of the 364 employees in the P1G. All personnel who worked in the high risk areas of ICU, CCU, Surgical SUite, Post-Anesthesia Care Unit, and Emergency Department were placed in Priority 1 Group (Table 1) .
A pre-program meeting was convened so that department managers would be involved. Each department manager was responsible for delivering directly to the employee an envelope which contained a letter about the program and a schedule of inservices. Once employees registered for the inservice of choice, they received a second envelope which contained a vaccine fact sheet and study of HBV infection in hospital personnel. After attendance at the education program, the employees were instructed to schedule an appointment for baseline serologic screening at the Occupational Employee Health Service.
Qualitative serology screening was performed using a solid phase enzymelinked immunoassay technique to measure levels of antibody to Hepatitis B surface antigen (Anti-HBs) (Ausab EIA, Abbott Laboratories, Method A). Three negative and two positive controls were assayed with each batch of specimens. Absorbance readings and calculations were done on a quantum analyzer. Presence or absence of antibody to Hepatitis B surface antigen was determined by comparing the absorbance of the employee specimens to a cutoff value. The cutoff value for each test batch was the mean of the negative controls plus a factor of .030 (Abbott Laboratories, 1983) .
Specimens with absorbance values less than the cutoff were considered non-reactive for Anti-HBs and personnel were potential vaccine recipients. Low range positives, those between the cut- off and 9.9 sample ratio units (SRU) were also classified as potential vaccine recipients. The borderline positives included false positives, low titer antibody to previous HBsAg exposure, previous vaccination or Hepatitis B Immune Globulin (HBIG) injection (Sampliner, 1984) . Specimens with an absorbance value above 10 SRU were considered positive for Anti-HBs. Employees in this range were questioned and health records examined to determine prior exposure to Hepatitis B, previousvaccination, or injection of HBIG. Recipients of HBIG were considered potential vaccinates.
Post-vaccination tests that were low range positive or negative were potential booster recipients. Booster recipients were considered positive on six-month retesting if above the cutoff value.
PROGRAM ANALYSIS
RESPONSE TO EDUCATION PRO-GR.4M: The education program was voluntary and 193 employees (53%) of the P1G attended. Of the 193 education participants, 171 (89%) requested serology. However, only 63 of the 193 (33%) education program participants received vaccination. Ten people who did not attend the education component were vaccinated. In total, 73 (20%) of the 364 high risk employees received the vaccination.
SEROLOGY AND IMMUNIZATION:
Baseline screening ws3s performed on 171 employees in the P1G. Of the 171 tested, 17(10%) were Anti-HBs positive. The baseline screening results identified 154 employees, 90% of the P1G, who were susceptible to Hepatitis Bvirus infection. All employees who were anti-HBs negative were informed of their susceptibility counseled on the mode of transmission of HBV and were encouraged to receive the vaccine. The 81 persons who declined immunization were again counseled on their susceptibility to HBV They were instructed to report any blood or body fluid exposures to the Occupational Health Service for evaluation of HBV infection risk.
The first of six separate immunization series for the Priority I Group began in October 1984 and ended in August 1985. Each employee received vaccination at 0, 1 and 6 months with Merck Sharp & Dohme Vaccine, Heptavax-B (1983) . Persons in the first three series received two immunizations in the gluteal and one in the deltoid muscles. Series 4 and 5 personnel received one gluteal and two deltoid immunizations. Series 6 employees received all vaccination doses in the deltoid muscle. The change in the vaccine administration site occurred because of information received from the Merck Sharp & Dohme Corporation in January 1985 which indicated the vaccine efficacy improved with deltoid administration.
A total of 74 persons began the immunization program and 73 completed the vaccination series. At least six weeks after the third injection, employees were tested for seroconversion. Fifty-three of the 73 vaccinates (73%) converted their Anti-HBs status from negative to positive after three doses of the vaccine. The 20 persons who did not seroconvert to Anti-HBs status consented to and received two booster doses of the vaccine. Eleven more persons (58%) seroconverted. In total, then, 64 of the 73 persons immunized (88%) demonstrated a response to the Hepatitis Bvaccine. Even after two booster doses, nine employees (12%) showed a negative response to the vaccine (Table 2) . Consequently, these nine employees were counseled regarding their susceptibility to Hepatitis BVirus infection. Because of the nearly 90% seroconversion rate, no attempt was made to establish the possible etiology of vaccination failures (Centers for Disease Control, 1982) .
Of the 64 persons who demonstrated a response to Heptavax-B, 36 returned for six-month follow-up testing. Immune status remained positive for 32 of those .~..... "--, ..~. . POST VACCINATION QUESTIONNAIRE RESPONSES: Immunized personnel were asked to complete a post-vaccination questionnaire to analyze the demographic data of the employee population (Grady, 1986) , There were 31 responses to the vaccine questionnaire. Employees who received the vaccine ranged from 26 to 61 years of age. The majority, 91.7%, were female. Employees had been in the health care industry from one to 40 years and had been employed at the Hospital from six months to 34 years.
Reasons that employees consented to the immunization series were grouped into six categories in order of frequency: • Available at No Cost; • Available at Work; • Perceived HBV Infection Risk; • Previous Exposure to HBV/HBIG Prophylaxis; • Increased Awareness; • Hospital Recommended. The seven of the 24 persons who had reservations about being immunized said they were afraid of the vaccine, possible reaction to or side effects from it, and any prolonged illness that mightoccur.
Side effects occurred in 12 and did not affect 19 employees. The symptoms cited were fever, myalgias, lethargy, nausea, diarrhea, local discomfort, lymph node tenderness, and cold or flu-like syndrome. In the majority of cases the symptoms lasted 24 hours to four days. Three vaccinates had symptoms over the course of several weeks. Seventeen persons sought add itional information on the vaccine prior to immunization; 14 did not. Sources of information were medical staff consultation, the occupational health service personnel, nursing literature, Merck Sharp & Dohme literature, colleagues, vaccinates, and the news media.
The vaccinated population was asked bout their feelings regarding immunization.~ost e~ployees were glad they were Immunized, and had a greater fe~l!ng of comfort when performing clinical and laboratory responsibilities. All 31 questionnaire respondents said they would consent to be immunized with the Heptavax-B again. In 28 cases, the employees would consider other immunizations (Table 3 ). Responses to the post-vac.cination questionnaire may reflect the bias of the population willing to receive a vaccine and complete a questionnaire.
CONCLUSIONS AND RECOMMENDATIONS
The education program had a positive effect on the number of personnel who were screened for and vaccinated against the Hepatitis B Virus infection. The rate of vaccine acceptance depended on the employee's perceived risk of Hepatitis B infection, immune status, perceived risk of acquiring AIDS from the vaccine, program effectiveness concem for vaccine efficacy, side ' effects, and the patient population in the community (Anderson & Hodges, 1983) .
We recommend mandatory orientation and annual education programs for personnel. At the very least, the education level of employees will be improved. Ideally, the number of vaccine recipients will increase. In addition, immune and non-immune employees should be counseled regarding employee responsibilities associated with blood, blood products, or body fluids exposures. We concluded that our employee population was at increased risk of infection because of their lack of immunity (90%), the Eastern Massachusetts Hepatitis outbreak, and the endemic but rising incidence of HBV infection in our community.
The pre-screening program was considered cost effective because 17 (10%) of our employee population demonstrated immunity. The 17 employees were deleted from the program for a cost avoidance of approximately $1,700.00. Pre-program screening may be cost effective if the institution's employee responsibilities have included exposures to populations at increased risk for Hepatitis B infection.
Because of the acceptable post-vaccination seroconversion rate (88%), no attempt was made to establish the etiology of vaccine failures. However, as more employees are vaccinated, the Most employees were glad they were immunized, and hada greater feeling of comfort when petforming clinical and laboratory responsibilities.
number of vaccine failures will be evaluated. In our particular population, the gluteal muscle administration of the vaccine was not considered to have a significant effect on the conversion rate (McClean, Guess & Scolnick, 1985) . Six-a~d 12-month post-vaccination serology Will document the employee's sustained or diminished immunity and need for booster doses. If yearly prospective serology is performed, the institution's program can supply the needed data on the longevity of seroconversion postvaccination.
We further recommend the development of personnel and employee health service policies to provide for preclinical immunization, employee screening, advisable staff relocation and exposure standards to prevent Hepatitis B infection (Hansen et aI., 1982) . In the future, program development should pursue a change in risk appraisal evaluation resulting in lower insurance premiums for the institution.
Finally, by developing and evaluating health risks and programs, specialty nurses can influence academic and health care administrations to address the need for infection control and occupational hazard education.
